STAGE IVA PROSTATE CANCER AJCC V8
Clinical trials for STAGE IVA PROSTATE CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVA PROSTATE CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IVA PROSTATE CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early-Stage trial halted after testing drug duo for tough prostate cancer
Disease control TerminatedThis early-stage trial aimed to see if adding a new oral drug (decitabine/cedazuridine) to a standard prostate cancer drug (enzalutamide) was safe and could help overcome treatment resistance. It involved 8 men with advanced prostate cancer that had spread and stopped responding …
Matched conditions: STAGE IVA PROSTATE CANCER AJCC V8
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Drug trial halted early for advanced prostate cancer
Disease control TerminatedThis study tested whether a drug called erdafitinib could help control advanced prostate cancer that had stopped responding to standard hormone treatments and spread to the bones. It involved 11 men and aimed to see if the drug could slow cancer growth and reduce bone-related mar…
Matched conditions: STAGE IVA PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Targeted drug duo tested for Tough-to-Treat prostate cancer
Disease control TerminatedThis study tested whether combining two drugs, apalutamide and abiraterone acetate, could better control advanced prostate cancer that had spread and stopped responding to standard hormone therapy. It aimed to see if this combination could slow the cancer's growth in men whose tu…
Matched conditions: STAGE IVA PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Targeted radiation tested to ease agony of cancer in bones
Symptom relief TerminatedThis study tested an experimental radioactive drug designed to target and treat cancer that has spread to the bones from prostate cancer. The main goal was to see if the treatment could provide lasting relief from the severe bone pain caused by these metastases. The trial was ter…
Matched conditions: STAGE IVA PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated Mar 30, 2026 14:33 UTC